糖皮质激素诱导的骨质疏松
摘要
内源性、外源性的糖皮质激素过多均可导致骨质疏松，糖皮质激素诱导的骨质疏松（glucocorticoid induced osteoporosis，GIOP）是继发性骨质疏松的最常见原因。
出处
《中华老年医学杂志》
CAS
CSCD
北大核心
2008年第1期76-78,共3页
Chinese Journal of Geriatrics
参考文献11
-
1Adinoff AD, Hollister Jr. Steroid-induced fractures and bone loss in patients with asthma. N Eng J Med, 1983,309:265-268.
-
2Vestergarrd P, Rejnmark L, Mosekilde L. Fracture risk associated with systemic and topical corticosteroids. J Intern Med, 2005, 257: 374-384.
-
3Van Staa TP, Leufkens HGM, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a metaanalysis. Osteoporos Int, 2002,13: 777-787.
-
4中华医学会,编著.临床诊疗指南骨质疏松症和骨矿盐疾病分册.北京人民卫生出版社,2006.第1版.16-18.
-
5Guidelines Working Group for the Bone and Tooth Society, National Osteoporosis Society and Royal College of Physicians. Glucocorticoid-induced-osteoporosis., guidelines for prevention and treatment. London: Royal College of Physicians, 2002
-
6No author. Recommendations for the prevention and treatment of gl ucocorticoid-induced osteoporosis : Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis:2001 update. American College of Rheumatology Ad Hoe Committee on Glucocorticoid- Induced Osteoporosis. Arthritis Rheum, 2001, 44: 1496-1503.
-
7Sambrook PN,Kotowicz M, Nash P,et al. Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, Vitamin D plus calcium, and slendronate plus calcium. J Bone Miner Res, 2003,18: 919-924.
-
8de Nijs RN, Jacobs JW, Lems WF, et al. Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis. N Engl J Med, 2006, 355:675-684.
-
9Hall GM, Daniels M, Doyle DV, et al. Effect of hormonal replacement therapy on bone mass in rheumatoid arthritis patients with and without steroids. Arthritis Rheum, 1994,37:1499-1505.
-
10Reid IR, Wattie DJ, Evans MC, et al. Testosterone therapy in glucocorticoid treated men. Arch Intern Med, 1996,156:1173-1177.
-
1吴琨,王国春,周惠琼.糖皮质激素诱导骨质疏松的诊治进展[J].中日友好医院学报,2010,24(5):307-310. 被引量：7
-
2蒋颖,张奉春,唐福林.糖皮质激素诱导的骨质疏松的防治策略[J].中华老年医学杂志,2008,27(7):559-560. 被引量：1
-
3张学武,刘湘源.再谈糖皮质激素诱导的骨质疏松的诊治[J].中华风湿病学杂志,2013,17(6):361-362. 被引量：7
-
4连莉,徐建华.糖皮质激素性骨质疏松防治进展[J].临床内科杂志,2011,28(10):653-655. 被引量：2
-
5吕锦,王金良.骨质疏松的生化标志物[J].医学检验与临床,2007,19(1):1-2.
-
6刘嘉鑫,王薇,韩剑锋,张霞.甲状腺疾病、糖尿病相关骨质疏松的病因研究进展[J].中国骨质疏松杂志,2014,20(2):210-213. 被引量：24
-
7文建梅,陈波.甲亢性骨质疏松52例临床分析[J].齐齐哈尔医学院学报,2009,30(2):170-170. 被引量：4
-
8邢小平.糖皮质激素诱导的骨质疏松[J].中国医刊,2006,41(10):8-10. 被引量：2
-
9周志伟.警惕悄悄降临的疾病骨质疏松症[J].生命与灾害,1998(5):21-22.
-
10唐守滦.激素性股骨头坏死的诊断和治疗[J].海峡药学,2000,12(z1):61-62.
